Comparative study of effectiveness and safety between non-Descemet stripping endothelial keratoplasty and Descemet stripping endothelial keratoplasty for endothelial decompensation
- PMID: 40463969
- PMCID: PMC12129991
- DOI: 10.3389/fmed.2025.1499422
Comparative study of effectiveness and safety between non-Descemet stripping endothelial keratoplasty and Descemet stripping endothelial keratoplasty for endothelial decompensation
Abstract
Purpose: To compare the potential effectiveness and safety of non-Descemet stripping endothelial keratoplasty (nDSEK) and Descemet stripping endothelial keratoplasty (DSEK) in treating endothelial decompensation.
Methods: A retrospective comparative analysis was conducted on patients with endothelial decompensation who underwent either nDSEK or DSEK procedures between August 2017 and January 2024. Participants were observed for a minimum duration of 12 months. The study documented key variables like best corrected visual acuity (BCVA), endothelial cell density (ECD), endothelial cell loss (ECL), and any issues that occurred during the follow-up period.
Results: A total of 85 eyes from 85patients (nDSEK n = 40 eyes, DSEK n = 45 eyes) were ultimately included in the study for analysis based on the inclusion and exclusion criteria. The mean BCVA (logMAR) showed significant improvement from the preoperative measurement of 1.66 ± 0.26 to 0.37 ± 0.11 in nDSEK eyes and from the preoperative 1.68 ± 0.24 to 0.36 ± 0.10 in DSEK eyes, respectively, at postoperative 12 months. However, there was no statistically significant difference in the improvement of BCVA between the nDSEK and DSEK eyes (p = 0.605). The mean donor ECD decreased from the preoperative 2,814 ± 85 cells/mm2 to 1,195 ± 216 cells/mm2 (ECL 57.5%) in nDSEK eyes and from the preoperative 2,889 ± 125 cells/mm2 to 1,266 ± 285 cells/mm2 (ECL 56.2%) in DSEK eyes, respectively, at postoperative 12 months, with no significant difference between the nDSEK and DSEK eyes (p = 0.192). The occurrence of various complications (e.g., graft dislocation, acute hypertension, primary graft failure, graft rejection) was comparable between nDSEK and DSEK eyes.
Conclusion: nDSEK eliminated the descemetorhexis step but yielded a comparable clinical outcome in effectiveness and safety compared to DSEK for treating endothelial decompensation.
Keywords: Descemet stripping endothelial keratoplasty; endothelial decompensation; endothelial keratoplasty; non-Descemet stripping endothelial keratoplasty; treatment.
Copyright © 2025 Huang, Yin, Hoang, Wu, Teng, Liang, Zhang and Wei.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Comparison and Correlation of the Donor-Recipient Interface Changes and Visual Outcomes Between nDSEK and DSEK.J Ophthalmol. 2025 Mar 12;2025:2066562. doi: 10.1155/joph/2066562. eCollection 2025. J Ophthalmol. 2025. PMID: 40224289 Free PMC article.
-
Endothelial keratoplasty without Descemet's stripping in congenital hereditary endothelial dystrophy.J AAPOS. 2013 Feb;17(1):22-4. doi: 10.1016/j.jaapos.2012.09.013. Epub 2013 Jan 24. J AAPOS. 2013. PMID: 23352381
-
Clinical results of non-Descemet stripping endothelial keratoplasty.Int J Ophthalmol. 2017 Feb 18;10(2):223-227. doi: 10.18240/ijo.2017.02.07. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28251080 Free PMC article.
-
Clinical characteristics, risk factor analysis and outcomes in 61 eyes with graft rejection after descemet stripping endothelial keratoplasty, with a review of literature.Int Ophthalmol. 2024 Nov 11;44(1):423. doi: 10.1007/s10792-024-03339-8. Int Ophthalmol. 2024. PMID: 39523234 Review.
-
Infectious interface keratitis (IIK) following lamellar keratoplasty: A literature review.Ocul Surf. 2019 Oct;17(4):635-643. doi: 10.1016/j.jtos.2019.08.001. Epub 2019 Aug 12. Ocul Surf. 2019. PMID: 31415815
References
LinkOut - more resources
Full Text Sources